TrialBlood2022

Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma.

Simone Ferrero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.